Diagnostics
Confirming a diagnosis of fragile X syndrome involves molecular genetic testing of the FMR1 gene. Physicians typically conduct this test when a combination of factors, such as developmental delays and a family history, are observed by parents or medical professionals. Prenatal testing is also available. While women carrying the mutated gene as a recessive allele do not exhibit any symptoms, they are more likely to experience ovarian failure at a young age compared to the general population. As a precautionary measure, obstetric doctors may advise young women facing difficulties conceiving to undergo genetic testing to determine if they are carriers.
Cognitive Symptoms
Understanding the impact of cognitive symptoms in Fragile X Syndrome (FXS)
Intellectual impairment is a common characteristic of Fragile X Syndrome and is typically more severe in males with FXS. In contrast, females with FXS tend to have milder intellectual impairment and may not exhibit noticeable cognitive symptoms. For males with FXS, specialized education and early intervention are crucial in helping them overcome cognitive challenges and learning disabilities. By providing tailored assistance from a young age, children with FXS can reach their full potential and lead fulfilling lives.